Bromide

Bromide

SCHEMBL18770834

C1CNCC[N+]2(C1)CC[N+]1(CCCNCC1)CC2.C1CNCC[N+]2(C1)CC[N+]1(CCCNCC1)CC2.[Br-].[Br-].[Br-].[Br-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL18770826 1.00 CXCR4 (0.37) CXCR4SMN1; SMN2ALDH1A1
Bromide SCHEMBL18770835 0.97 CXCR4 (0.35) CXCR4SMN1; SMN2ALDH1A1
SCHEMBL18770798 0.97 CXCR4 (0.39) CXCR4SMN1; SMN2ALDH1A1
Bromide SCHEMBL18770824 0.91 CXCR4 (0.32) CXCR4SMN1; SMN2ALDH1A1
SCHEMBL18770812 0.88 CXCR4 (0.33) CXCR4SMN1; SMN2ALDH1A1
Bromide SCHEMBL1567698 0.87 HIF1A (0.36)
Bromide SCHEMBL10885562 0.85 CXCR4 (0.32) CXCR4SMN1; SMN2ALDH1A1
SCHEMBL4905025 0.84 CXCR4 (0.35) CXCR4SMN1; SMN2ALDH1A1
SCHEMBL12604569 0.84 HIF1A (0.39) CXCR4SMN1; SMN2ALDH1A1
SCHEMBL4977472 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017069661-A1 PYRIMIDYL-DI(DIAZASPIRO-ALKANES) WITH ANTIVIRAL ACTIVITY Limited Liability Company “Nearmedic Plus” (RU) 2017-04-27 WO disclosed